Transplant Diagnostics Market Size, Share & Trends by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User & Region - Global Forecast to 2028
Transplant Diagnostics Market Size, Share & Trends
The size of global transplant diagnostics market in terms of revenue was estimated to be worth $4.4 billion in 2022 and is poised to reach $6.8 billion by 2028, growing at a CAGR of 7.4% from 2022 to 2028. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
Increased impact of infectious diseases. The number of people with end-stage organ failure has been rising, and due to advancements in transplantation, a larger percentage of people are now eligible for organ transplantation. This growing need is a result of these two factors. Increasing public and private funding for transplantation and various organ transplant awareness campaigns.
Transplant Diagnostics Market Trends
To know about the assumptions considered for the study, Request for Free Sample Report
e- Estimated; p- Projected
Transplant Diagnostics Market Dynamics
Driver: Increasing number of transplant procedures.
The rising adoption of several technologies and screening tests, genomic profiling and cross-matching are making transplants a suitable way of giving life or rebirth of the individual. The rising number of transplant procedures across major countries can be attributed to the rising CAGR of the transplant market. For instance, in the U.S 41,354 organ transplants were carried out in 2021, France 5,273 organ transplants in 2021. Diseases such as TB, end-stage renal diseases and liver cirrhosis are common among geriatric individuals and it makes it a compulsion for the individual to undergo transplant surgery.
Opportunity: Growing public awareness about organ donation and transplantation.
In 2022, the American Transplant foundation organized a fundraising event namely DLA Awards to support programs that promote public awareness related to organ donations and transplantations In 2021, the Organ receiving and giving awareness network (India) conducted an awareness program that aimed to strengthen public willingness to donate organs for transplantation procedures in India.In US long runs of 3kms,5kms and 10kms are organized to promote organ transplants within the public and make them aware of the necessity of giving life to others.
Challenge: Significant gap between number of organs donors and organs required.
There is a significant gap between number of organs donated annually and number of organs donations required. The limited number of organs donated annually across the globe is primarily due to strict government enforcement and limited medical reimbursements for living organ donors and lack of awareness about organ donations.
Restraint: High procedural cost of NGS and PCR-based diagnostic assays
Transplant diagnostic procedures for Histocompatibility tests,blood profiling,genomic profiling are conducted through specialized molecular diagnostic platforms that consists of several advanced technologies. These technologies are integrated with conventional PCR/NGS instruments and thus the cost of these advanced products is on the higher edge.
Market Ecosystem
By technology, the molecular assay technologies segment accounted for the largest share of the transplant diagnostics market during the forecast period.
In 2022, molecular assay technologies accounted for the largest share of in the market. This segment is projected to reach USD 6,156.9 million in 2028 from USD 4,166.0 in 2022, at a CAGR of 8.0% during the forecast period. Molecular assays are used in transplant diagnostic procedures for donor-recipient compatibility testing. The growing demand for molecular assays during transplant diagnostic procedures is mainly attributed to the technological benefits offered by these assays as compared to non-molecular assays, such as high procedural efficacy, the study of multiple samples and real time analysis.
By End User, Independent reference laboratories is expected to grow at the fastest rate in the transplant diagnostics market during the forecast period.
In 2022, Independent reference laboratories hold a larger share In the market with a share of 58.65%. This end-user segment is projected to reach USD 4,233.9 in 2028 from USD 2,668.8 in 2022. This end-user segment is also expected to grow at the highest CAGR of 8.0% during the forecast period. The large share of this segment can be attributed to the rapid modernization and automation of diagnostic laboratories and growing number of research and developmental activities.
By Product & Services, the Reagents & Consumables segment holds the largest share of the transplant diagnostics market.
In 2022, Reagents & Consumables holds the largest around 72.2% in the market. This Product & Service segment is projected to reach USD 5,131.0 million in 2028 from USD 3,265.2 million in 2022. Reagents & consumables account for the largest share of transplant diagnostics. Expansion in the application horizons of molecular assay techniques in transplant diagnostics, increasing patient emphasis on effective and early patient profiling during organ transplantation.
By Application, Infectious disease testing accounted for the largest share of the transplant diagnostics market during the forecast period.
In 2022, Infectious disease testing is projected to reach USD 3,764.3 million in 2028 from USD 2,344.0 million in 2022.A number of factors, such as ongoing technological advancements in the field of molecular assay techniques, the increasing adoption of these techniques for pathogen detection and histocompatibility testing and the rising incidence of infectious chronic diseases is helping this segment to grow at a high CAGR.
North America is expected to be the largest region in the transplant diagnostics market during the forecast period.
North America, comprising the US and Canada, accounted for the largest share of 45.4% of the market in 2022. Factors such as the high prevalence of diseases, the rising geriatric population, emergence of infectious diseases is contributing to the large share of North America.
APAC region is growing at the highest CAGR of 8.3% due to increasing organ donations and various public and private reimbursements policies.
To know about the assumptions considered for the study, download the pdf brochure
As of 2021, prominent players in the market are include bioMérieux SA (France), Becton, Dickinson, and Company (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories, Inc. (US) among others.
Transplant Diagnostics Market Report Scope:
|
Report Metric |
Details |
|
Market size available for years |
2020–2028 |
|
Base year considered |
2021 |
|
Forecast period |
2022–2028 |
|
Forecast units |
Value (USD) |
|
Segments covered |
Technology, Product & Service, Application, Transplant type, End User & Region |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and Middle East and Africa |
|
Companies covered |
include bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), RMerck KGaA (US), |
This report categorizes the global transplant diagnostics market into following segments & sub-segments:
By Technology
-
Molecular assay technologies
- PCR-based molecular assays
- Real-time PCR
- Sequence-specific primer-PCR
- Sequence-specific Oligonucleotide-PCR
- Other PCR-based molecular assays
-
Sequencing based molecular assays
- Sanger sequencing
- Next generation sequencing
- Other sequencing based molecular assays
- Non molecular assays technologies
By Product & Service
- Reagents & Consumables
- Instruments
- Software & Services
By Application
-
Diagnostic application
-
Pre-transplantation Diagnostics
- Infectious Disease testing
- Histocompatibility testing
- Blood profiling
- Post -transplantation Diagnostics
-
Pre-transplantation Diagnostics
- Research applications
By transplant type
-
Solid Organ Transplantation
- Kidney transplantation
- Liver transplantation
- Heart transplantation
- Lung transplantation
- Pancrease transplantation
- Other Organs transplantation
- Stem Cell transplantation
- Soft tissue transplantation
- Bone marrow transplantation
By End User
- Hospitals and Transplant centers
- Research &Academic Institutes
- Independent reference laboratories
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia Pacific
-
Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Recent Developments
- In February 2023, BD received FDA approval for BD Onclarity HPV assay in the serology testing segment
- In March 2023 BioRad received AQAC International and AFNOR approval for its iQ-Check kits.
- Hoffmann-La Roche Ltd. unveiled Cobas Infinity edge, a cloud-based point-of-care platform that is available everywhere, in January 2022. Practitioners in the healthcare industry can manage patient data thanks to advanced technology. This has aided the business in diversifying its product offering.
Frequently Asked Questions (FAQ):
What is the projected market value of the global transplant diagnostics market?
The global market of transplant diagnostics is projected to reach USD 6.8 billion.
What is the estimated growth rate (CAGR) of the global transplant diagnostics market for the next five years?
The global transplant diagnostics market in terms of revenue was estimated to be worth $4.4 billion in 2022 and is poised to grow at a CAGR of 7.4%.
What does the current study of the transplant diagnostics market consist of?
The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the microcatheter market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the medical aesthetic market. The primary sources from the demand side include medical OEMs, Oncologists, CDMOs and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2021, Tier 1 = >USD 1,000 million, Tier 2 = USD 500–1,000 million, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Estimation Methodology
In this report, the transplant diagnostic market size was arrived at by using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the transplant diagnostic business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.
To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/service providers. This process involved the following steps:
- Generating a list of major global players operating in the transplant diagnostic market
- Mapping annual revenues generated by major global players from the product segment (or nearest reported business unit/product category)
- Revenue mapping of major players to cover major share of the global market share, as of 2021
- Extrapolating the global value of the transplant diagnostic market
To know about the assumptions considered for the study, Request for Free Sample Report
Approaches
Bottom-up Approach
- For estimating the size of the transplant Diagnostics market, the country-level market revenues were obtained from secondary sources and through extensive primary interviews
- Country-level markets for the US and Canada were added to arrive at the market size for North America. Similarly, country-level markets for other countries were added to arrive at the market size of Europe and Asia Pacific.
- The total market derived through the bottom up approach was again validated through secondary sources and primaries.
Top-down approach
- The overall market size derived from the bottom-up approach was used in the top-down procedure to estimate the size of the subsegment.
- Percentage splits were applied to the total market size (splits were obtained from secondary and primary research) to obtain the market size for each subsegment.
- The top-down approach was used to reach the regional and country-level market size for these subsegments.
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the Transplant Diagnostic market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the transplant diagnostic market was validated using both top-down and bottom-up approaches.
Market definition
Transplant diagnostic procedures are used to determine donor-recipient compatibility to avoid immune rejection in a recipient. These procedures are adopted for donor-recipient cross-matching, subject profiling, genotyping and other related diagnostic tests. Advanced genomic techniques(such as PCR and NGS) are increasingly being used during transplant diagnostic procedures, apart from serological and other conventional techniques for immune-compatibility testing.
Key stakeholders
- Transplant Diagnostic product manufacturing companies.
- Healthcare service providers (Including hospitals, transplant centers and blood transfusion centers)
- Blood, tissue and stem cell banks
- Government Organizations
- Independent association and regulatory authorities
- R&D companies
- Independent reference laboratories
- Diagnostic Laboratories
- Clinical Research organizations
Objectives of the Study
- To define, describe, and forecast the Transplant diagnostic marketon the basis of Technology, Product & Service, Application,End User & Region.
- To provide detailed information regarding the major factors influencing the growth potential of the transplant diagnostic market(drivers, restraints, opportunities, challenges, and trends)
- To analyze the micro markets with respect to individual growth trends, future prospects, and contributions to the Transplant diagnostic market
- To analyze key growth opportunities in the Transplant diagnostic market for key stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, Thailand, Indonesia and the RoAPAC), Latin America (Brazil, Mexico, and RoLATAM), and the Middle East & Africa
- To profile the key players in the Transplant diagnostic market and comprehensively analyze their market shares and core competencies
- To track and analyze the competitive developments undertaken in the transplant diagnostic market, such as product launches; agreements; expansions; and mergers & acquisitions
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present transplant diagnostic market;
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of the top five companies
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Europe Transplant diagnostic marketinto Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal among other
- Further breakdown of the Rest of the Asia Pacific Transplant diagnostic marketinto Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
- Further breakdown of the Latin American Transplant diagnostic market into Colombia, Chile, Argentina, and Peru, among other
Generating Response ...
Growth opportunities and latent adjacency in Transplant Diagnostics Market